Abstract. Adenomatous polyposis coli (APC) germline mutations are responsible for the occurrence of familial adenomatous polyposis (FAP). Somatic mutations lead to malignant transformation of adenomas. In this context, considering the significance of APC germline mutations in FAP, we aimed to identify APC germline mutations. In the present study, 20 FAP patients were enrolled. The determination of APC germline mutations was performed using sequencing, and the mutations were compared with clinical markers (gender, age at diagnosis, smoking habits, TNM stage, Astler-Coller stage, degree of differentiation of adenocarcinoma). The data were compared using the SPSS program, with the Fisher's exact test and χ 2 test, considering α=0.05. According to the main results in our sample, 16 alleles with deleterious mutations (80% of the patients) were identified while 7 (35%) patients had no deleterious mutations. There was a predominance of nonsense (45% of the patients) and frameshift (20% of the patients) mutations. There was no statistical significance between the APC germline mutations identified and the clinical variables considered in our study. Only TNM stage was associated with the presence of deleterious mutations. Patients with deleterious mutations had an OR, 0.086 (IC=0.001-0.984); TNM stage I + II in comparison with III + IV, when compared with the patients with no deleterious mutations identified. In this context, as a conclusion, we demonstrated the molecular heterogeneity of APC germline mutations in FAP and the difficulty to perform molecular diagnostics in a Brazilian population, considering the admixed population analyzed.
Introduction
Colorectal cancer is common in Brazil. In the year 2012, 14,180 new cases of colon and rectum cancer were expected to occur in men and 15,960 in women. These values correspond to an estimated risk of 15 new cases per 100,000 men and 16 cases per 100,000 women (1) .
Excluding non-melanoma skin tumors, colon and rectum cancer is the second most common cancer among men in Southeast Brazil (22/100,000) and third in South (18/100,000) and Midwest (14/100,000) Brazil (1) . In North Brazil (4/100,000) this cancer ranks fourth; in Northeast Brazil (5/100,000), fifth. Among women, it is the second most common cancer in Southeast (23/100,000) and South Brazil (20/100,000), the third in Midwest (15/100,000) and Northeast Brazil (7/100,000), and sixth in the North (5/100,000) (1) .
Familial adenomatous polyposis (FAP) is one of the most clearly defined and well understood inherited colorectal cancer syndrome. It is an autosomal dominant disorder that typically presents in the form of colorectal cancer in young adults secondary to extensive adenomatous polyposis present in the colon (2) .
The adenomatous polyposis coli (APC) gene is on chromosome 5q21 and displays alternative splicing in multiple coding and noncoding regions of the DNA sequence, and the primary transcript has 15 exons. The APC gene has 8,532 base pairs corresponding to 2,844 amino acids, resulting in a 311.8-kDa protein. Exon 15 has the largest extension, making up more than three quarters of the coding region (3) .
Approximately 737 APC gene mutations, including 332 germline and 402 somatic have been identified. APC germline mutations are responsible for the occurrence of FAP, and somatic mutations have been associated with malignant transformation of adenomas (4) . Almost all mutations lead to truncation of the APC protein either by nonsense (30%) or by frameshift mutations (68%). The majority of mutations occur within the first half of the coding sequence. In an American study, in which 1,591 patients were studied, of the 431 pathogenic or likely pathogenic mutations, frameshift, nonsense, splice sites and large deletion or duplication mutations represented 43, 42, 9 and 6% of cases, respectively (5) .
APC germline mutations are predominate at the 5' end of the gene, while somatic mutations mainly occur in the region called the mutation cluster region (MCR) between codons 1,284 and 1,580 of the APC gene. In germline mutations, two hot spot codons have been identified; one at position 1,061 and the second at position 1,309. In somatic mutations, two hot spots seem to occur at position 1,309 and 1,450 (3) .
Several studies have attempted to correlate specific APC mutations with clinical phenotypes. Mutations between codons 169 to 1,578 have been generally associated with the classic form of FAP. Mutations between codons 1,445 and 1,578 have been associated with desmoid tumors, whereas mutations between codons 279 to 1,309 have been correlated with the development of duodenal polyposis (6) .
Based on the findings in the literature, the objective of the present study was to detect APC germline mutations that affect families followed up at the Oncology Clinic of the University of Campinas (Unicamp) and to compare the identified mutations with clinical variables.
Materials and methods
We recruited 20 nonrelative patients at the Oncology Service in the 'Gastrocentro' of the Faculty of Medical Sciences of Unicamp. The present study included families that had two or more successive generations affected by FAP (>100 polyps); no polyposis colorectal cancer was present. The project was approved by the university ethics committee (#874/2008). All patients and/or their guardians signed an informed consent form.
Clinical variables.
The clinical variables analyzed in our samples included gender (male/female), age at diagnosis (≤41 or >41 years), smoking habits (passive smoking, smoker, nonsmoker), TNM stage (I + II vs. III + IV), Astler-Coller stage (B1 + B2 vs. C1 + C2), degree of differentiation of adenocarcinoma (moderately differentiated, poorly differentiated, well-differentiated).
All of the variables were evaluated by medical specialists including special considerations to TNM stage (tumor, lymph node, metastasis), Astler-Coller stage and degree of differentiation of the adenocarcinoma and were evaluated taking into account previously literature (6-10).
DNA extraction. Genomic DNA was obtained by direct extraction from lymphocytes of peripheral blood according to standard procedures (11) . DNA samples were quantified using the NanoVue ® v1.7.2 spectrophotometer (GE Healthcare, Chicago, IL, USA). For all analyses performed, 50 ng/µl was used to improve the polymerase chain reaction (PCR) technique.
DNA sequencing and analysis. To identify APC mutations, DNA fragments containing the entire coding region and intron-exon boundaries of the APC gene were amplified, using PCR conditions as published by Miyoshi et al (12) , Nagase et al (13) and Gómez-Fernández et al (14) , with primers as listed in Table I . The precise gradients for temperature and buffers providing the optimal temperature for each fragment were determined experimentally. The PCR products 
APC, adenomatous polyposis coli. indicating heterozygosity were sequenced using the Applied Biosystems (ABI) Prism BigDye Terminator v3.1 cycle sequencing kit and ABI 3500XL DNA sequencer (PE Applied Biosystems, Foster City, CA, USA), using identical conditions as previously published (12) (13) (14) 
Results
In the descriptive analysis, the average age at diagnosis of the patients was 42.85 years (±6.892), and the age range was from 29 to 55 years. Of the 20 patients, 18 (90%) were Caucasian and 2 (10%) were not Caucasian; 14 (70%) were females and 6 (30%) were males. The clinical data are summarized in Table II . The frequency of cases for each stage according to the TNM system was 2 (10%), 6 (30%), 6 (30%) and 6 (30%), respectively, for stage I, II, III and IV. The frequency of cases for each stage according to the Astler-Coller system was 2 (10.5%), 5 (26.4%), 2 (10.5%) and 10 (52.6%), respectively, for stages B1, B2, C1 and C2. A smoking habit was observed in 8 patients, 2 (10%) were occasional smokers and 6 (30%) were smokers; the remaining patients (60%) were non-smokers. Two patients (10%) had well-differentiated adenocarcinoma, TNM system: T, describes how far the main (primary) tumor has grown into the wall of the intestine and whether it has grown into nearby areas; N, describes the extent of spread to nearby (regional) lymph nodes; M, indicates whether the cancer has spread (metastasized) to other organs of the body. Astler-Coller classification: A, tumor limited to the mucosa, carcinoma in situ; B1, tumor grows through muscularis mucosa but not through muscularis propria; B2, tumor grows beyond muscularis propria; C1, stage B1 with regional lymph node metastases; C2, stage B2 with regional lymph node metastases; D, distant metastases. Statistical analysis conducted by Fisher's exact test and χ 2 test. In bold print, P-values <0.05. OR, odds ratio; CI, confidence interval; NS, non-smoker; PS, possible smoker; S, smoker; MD, moderately differentiated; PD, poorly differentiated; WD, well-differentiated. 15 (75%) had moderately differentiated and 3 (15%) had poorly differentiated adenocarcinoma.
TNM stage ----------------------------------------------------
For the determined mutant alleles, 16 (40%) were deleterious and 7 (17.5%) were not deleterious. Associations were Astler-Coller classification: A, tumor limited to mucosa, carcinoma in situ; B1, tumor grows through muscularis mucosa but not through muscularis propria; B2, tumor grows beyond muscularis propria; C1, stage B1 with regional lymph node metastases; C2, stage B2 with regional lymph node metastases; D, distant metastases. TNM system: T, describes how far the main (primary) tumor has grown into the wall of the intestine and whether it has grown into nearby areas; N, describes the extent of spread to nearby (regional) lymph nodes; M, indicates whether the cancer has spread (metastasized) to other organs of the body. Statistical analysis conducted by Fisher's exact test and χ 2 test. In bold print, P-values <0.05. OR, odds ratio; CI, confidencial interval; WD, well-differentiated; MD, moderately differentiated; PD, poorly differentiated; NS, non-smoker; S, smoker; PS, possible smoker. For the deleterious mutations detected, we found a prevalence of nonsense mutations, with 9 (45%) mutant alleles. In 4 (20%) patients small deletions were noted, while 3 (15%) patients had missense mutations, and 3 (15%) patients had only neutral polymorphisms and 1 (5%)patient had no mutations found in the exons. In 60% of patients, extra-colonic manifestations were present; the most common being gastric polyps, duodenal and in the small bowel (Table II) .
In Figs. 1 and 2 , the APC gene and all mutations identified were described in details. In the same figures, the protein structure is described, considering the principal mutation sites and their association with FAP.
Associations between the clinical variables and the identified APC germline mutations could not be calculated as the sample size was small and some of the mutations were not deleterious.
Discussion
The high molecular heterogeneity in the APC gene was consistent with other studies in FAP patients (12, 18) . Mutations c.3927_3931delAAAGA and pTyr935X were found in 2 patients. The c.3927_3931delAAAGA mutation occurs in exon 15 and leads to formation of a stop codon at position 1,312. It is the most frequent mutation in the APC gene. Its frequency varies from 0% in southwest Spain to 2.4% in the Australian population, 5% in the Dutch population, 7% in the Israeli population, and up to 16% in Italian FAP patients (19) (20) (21) (22) . The pTyr935X mutation is a nonsense alteration of exon 15 that exchanges cytosine for adenine.
In our sample, we found a predominance of nonsense mutations (45% of the patients), followed by frameshift mutations (20% of patients). Among the 6 (30%) patients with neutral mutations, missense mutations occurred in more than 1 patient. We found the missense mutation, Gly2502Ser. According to Azzopardi et al (18) , who studied 691 patients with colorectal adenomas and 969 healthy individuals (individuals investigated for cystic fibrosis), this mutation can be found in individuals with or without adenoma, leaving a doubt as to whether this mutation is deleterious. The mutation Glu1317Gln is described in the literature as being deleterious (23) (24) (25) (26) (27) , although other studies considered it to be not deleterious. Azzopardi et al (18) found this mutation in both healthy subjects and in adenoma patients. However, we need further monitoring and analysis of these individuals with the family to gain a better understanding of this result.
For the variety of mutations, we were unable to determine a correlation between the clinical variables and the mutations detected. It is necessary to expand the sample to support such analysis. Yet, following analysis of the correlation of the presence of deleterious mutations and TNM and Astler-Coller stage, we found a positive correlation with the presence of deleterious mutations, demonstrating a more severe disease. Patients with deleterious mutations had an OR, 0.086 (IC =0.001-0.984); TNM stage I + II in comparison with III + IV, when compared with the patients with no deleterious mutations identified.
In conclusion, our study demonstrated the molecular heterogeneity of APC germline mutations in FAP and the difficulty in performing molecular diagnostics in a Brazilian population, since there were no mutations noted with a higher prevalence. Thus, molecular diagnostics requires further detailed evaluation, which, however is hampered by the presence of neutral mutations, and these mutations are still debatable in many populations of the world.
